共 89 条
[1]
Lambert LA(2015)Looking up: recent advances in understanding and treating peritoneal carcinomatosis CA Cancer J Clin 65 284-298
[2]
Chakraborty A(2011)Malignant bowel obstruction: naturalhistory ofaheterogeneouspatient population followed prospectively overtwoyears J Pain Symptom Manag 41 412-420
[3]
Selby D(2016)Patients with peritoneal carcinomatosis from gastric cancer treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: is cure a possibility? Ann Surg Oncol 23 1971-1979
[4]
Gardiner K(2014)Intraperitoneal chemotherapy of peritoneal carcinomatosis using pressurized aerosol as an alternative to liquid solution: first evidence for efficacy Ann Surg Oncol 21 553-559
[5]
Myers J(2018)Pressurized intraperitoneal aerosol chemotherapy (PIPAC) for the treatment of malignant mesothelioma BMC Cancer 18 442-1855
[6]
Moravan V(2012)Description of a novel approach for intraperitoneal drug delivery and the related device Surg Endosc 26 1849-107
[7]
Wright F(2016)Peritoneal sampling and histological assessment of therapeutic response in peritoneal metastasis: proposal of the peritoneal regression grading score (PRGS) Pleura Peritoneum 1 99-1385
[8]
Chia CS(2018)Feasibility, safety, and efficacy of pressurized intraperitoneal aerosol chemotherapy (PIPAC) for peritoneal metastasis: a registry study Gastroenterol Res Pract 2018 2743985-678
[9]
You B(2015)Quality of life of patients with end-stage peritoneal metastasis treated with pressurized intraperitoneal aerosol chemotherapy (PIPAC) Eur J Surg Oncol 41 1379-257
[10]
Decullier E(2017)Impact of pressurized intraperitoneal aerosol chemotherapy on quality of life and symptoms in patients with peritoneal carcinomatosis: a retrospective cohort analysis Gastroenterol Res Pract 2017 4596176-314